台股 » 個股 » 生華科 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

生華科

(6492)
可現股當沖
  • 股價
    44.25
  • 漲跌
    ▼0.05
  • 漲幅
    -0.11%
  • 成交量
    59
  • 產業
    上櫃 生技醫療類股
  • 154人加入追蹤

    立即追蹤

  • 本地時間:13:30

     
生華科 (6492)籌碼相關-元大-善化 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

元大-善化 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2025/02/2500.00345.5045.60-3153-1.96%
2025/02/14044.7000.0044.8001630.00%
2025/02/12043.9500.0044.0501680.01%
2025/01/22842.3000.0042.3082283.51%
2025/01/20141.6500.0041.6513780.26%
2025/01/1000.00043.4043.3503870.00%
2025/01/09044.9500.0043.9503860.00%
2024/12/27145.6000.0044.2514210.24%
2024/12/18342.3000.0042.3035150.58%
2024/12/09143.8000.0043.8016000.17%
2024/11/2800.00244.1544.45-2645-0.31%
2024/11/18044.3500.0044.1006990.00%
2024/11/14246.4500.0046.4527050.28%
2024/11/08049.1100.0048.6007350.00%
2024/11/06049.5500.0049.3507460.00%
2024/11/04049.8000.0049.7007740.00%
2024/11/01049.9000.0050.0007780.00%
2024/10/3000.001051.5050.50-10777-1.29%
2024/10/281855.803.153.1552.60157561.98%
2024/10/09149.3000.0049.1511,0590.09%
2024/10/08051.3000.0050.8001,0520.00%
2024/09/2700.00055.0054.7001,0350.00%
2024/09/2500.00153.6053.80-11,018-0.10%
2024/09/2400.00155.3053.40-11,019-0.10%
2024/09/23254.45054.7054.6021,0190.20%
2024/09/2000.001055.0055.00-101,023-0.98%
2024/09/19155.30155.4053.2009950.00%
2024/09/1800.00152.3052.30-1943-0.11%
2024/09/11147.2500.0046.6511,0060.10%
2024/09/0900.00147.7048.20-11,034-0.10%
2024/09/06047.0500.0046.5501,0230.00%
2024/09/03150.8000.0051.4011,0070.10%
2024/08/29151.6000.0050.0019930.10%
2024/08/2200.00149.7549.80-1962-0.10%
2024/08/1600.00349.4850.10-3928-0.32%
2024/08/15449.84249.7349.6029170.22%
2024/08/13047.2500.0047.1008940.00%
2024/08/12148.15148.3048.1508850.00%
2024/08/091048.1500.0048.15108791.14%
2024/08/08049.5000.0049.7508650.00%
2024/08/07050.3000.0050.7008560.00%
2024/08/05147.700.147.9047.700.98180.11%
2024/07/26153.6000.0054.5017760.13%
2024/07/230.155.81557.1254.10-4.9770-0.64%
2024/07/225.159.17058.4056.205.17520.67%
2024/07/1900.00758.9658.10-7735-0.95%
2024/07/1816.161.842463.2562.20-7.9658-1.21%
2024/07/17058.20958.5058.90-9543-1.66%
2024/07/16856.871357.0457.20-5427-1.17%
2024/07/11143.1500.0043.0013180.31%
2024/07/10143.4500.0043.3513190.31%
2024/07/0300.00145.0545.00-1308-0.32%
2024/07/02345.6200.0045.5033070.98%
2024/06/2600.00149.1048.75-1288-0.35%
2024/06/24146.2500.0045.5012620.38%
2024/06/204.748.77347.8747.601.72500.67%
2024/06/19247.50147.9547.9512240.45%
2024/06/18145.35246.3544.00-1213-0.47%
2024/06/17145.2000.0045.3511870.53%
2024/05/1000.00441.2341.10-4180-2.21%
2024/04/18041.9500.0041.9001820.00%
2024/04/12043.95443.6543.30-4186-2.14%
2024/04/0200.00043.6543.9501920.00%
2024/03/29044.3500.0044.1001980.00%
2024/03/27043.9500.0043.5002000.00%
2024/03/22043.3500.0043.1501980.00%
2024/03/21043.1500.0042.7002000.00%
2024/03/14042.9500.0042.9002050.00%
生華科新藥再獲孤兒藥資格 上市可獲7年市場獨賣保護期Anue鉅亨-2024/10/25
上櫃「肥貓」董監現形 台嘉碩、大宇資、穩懋、生華科為前四肥Anue鉅亨-2024/04/15
生華科治療新冠、流感等泛病毒感染新藥 將啟動二期臨床Anue鉅亨-2023/11/21
生華科 相關文章
生華科 相關影音